Epsilon Healthcare Ltd (EPN) - Total Liabilities

Latest as of December 2025: AU$14.88 Million AUD ≈ $10.53 Million USD

Based on the latest financial reports, Epsilon Healthcare Ltd (EPN) has total liabilities worth AU$14.88 Million AUD (≈ $10.53 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore EPN cash flow conversion to assess how effectively this company generates cash.

Epsilon Healthcare Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Epsilon Healthcare Ltd's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Epsilon Healthcare Ltd to evaluate the company's liquid asset resilience ratio.

Epsilon Healthcare Ltd Competitors by Total Liabilities

The table below lists competitors of Epsilon Healthcare Ltd ranked by their total liabilities.

Company Country Total Liabilities
Aptorum Group Ltd Class A
NASDAQ:APM
USA $4.90 Million
First Venture Sweden AB Series B
ST:FIRST-B
Sweden Skr851.00K
Computer Forms (Malaysia) Bhd
KLSE:8044
Malaysia RM5.92 Million
Saehwa IMC Co Ltd
KO:145210
Korea ₩66.64 Billion
ConnectM Technology Solutions, Inc.
NASDAQ:CNTM
USA $40.77 Million
Permsin Steel Works Public Company Limited
BK:PERM
Thailand ฿3.60 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Epsilon Healthcare Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Epsilon Healthcare Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.14 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 4.98 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.83 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Epsilon Healthcare Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Epsilon Healthcare Ltd (2016–2025)

The table below shows the annual total liabilities of Epsilon Healthcare Ltd from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 AU$14.88 Million
≈ $10.53 Million
+28.63%
2024-12-31 AU$11.57 Million
≈ $8.18 Million
+68.29%
2023-12-31 AU$6.87 Million
≈ $4.86 Million
-38.80%
2022-12-31 AU$11.23 Million
≈ $7.95 Million
+2.27%
2021-12-31 AU$10.98 Million
≈ $7.77 Million
-8.06%
2020-12-31 AU$11.94 Million
≈ $8.45 Million
+117.47%
2019-12-31 AU$5.49 Million
≈ $3.89 Million
+17.90%
2018-12-31 AU$4.66 Million
≈ $3.30 Million
+691.15%
2017-12-31 AU$588.83K
≈ $416.63K
+403.30%
2016-12-31 AU$116.99K
≈ $82.78K
--

About Epsilon Healthcare Ltd

AU:EPN Australia Drug Manufacturers - Specialty & Generic
Market Cap
$5.51 Million
AU$7.78 Million AUD
Market Cap Rank
#28158 Global
#1534 in Australia
Share Price
AU$0.02
Change (1 day)
+0.00%
52-Week Range
AU$0.02 - AU$0.04
All Time High
AU$1.08
About

Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in two segments, Contract Development and Manufacturing Activities; and Telehealth Medical Practice Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmace… Read more